Beijing Luzhu Biotechnology Co (HKSE:02480) Other Stockholders Equity: HK$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02480 Beijing Luzhu Biotechnology Co Ltd HKSE:02480
24 GF Score
Price HK$14.00
! 3 Warning Signs
View Full Analysis

What is Beijing Luzhu Biotechnology Co Other Stockholders Equity?

Beijing Luzhu Biotechnology Co HKSE:02480 24 Other Stockholders Equity is HK$0.00 Mil as of Dec. 2025. GuruFocus rates HKSE:02480 with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Beijing Luzhu Biotechnology Co's Other Stockholders Equity for the quarter that ended in Dec. 2025 was HK$0.00 Mil.

Beijing Luzhu Biotechnology Co's quarterly Other Stockholders Equity increased from Dec. 2024 (HK$-0.00 Mil) to Jun. 2025 (HK$-0.00 Mil) and increased from Jun. 2025 (HK$-0.00 Mil) to Dec. 2025 (HK$0.00 Mil).

Beijing Luzhu Biotechnology Co's annual Other Stockholders Equity declined from Dec. 2023 (HK$152.88 Mil) to Dec. 2024 (HK$-0.00 Mil) but then increased from Dec. 2024 (HK$-0.00 Mil) to Dec. 2025 (HK$0.00 Mil).

Beijing Luzhu Biotechnology Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Beijing Luzhu Biotechnology Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Luzhu Biotechnology Co Other Stockholders Equity Chart

Beijing Luzhu Biotechnology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
55.93 73.91 152.88 -0.00 0.00

Beijing Luzhu Biotechnology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 152.88 0.00 -0.00 -0.00 0.00
HKSE:02480
24GF Score
Beijing Luzhu Biotechnology Co Ltd HKSE:02480
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Luzhu Biotechnology Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$0.00 Mil mean?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a Other Stockholders Equity of HK$0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Beijing Luzhu Biotechnology Co and its competitors.
Is Beijing Luzhu Biotechnology Co's Other Stockholders Equity too high?
Beijing Luzhu Biotechnology Co's current Other Stockholders Equity is HK$0.00 Mil. Overall, Beijing Luzhu Biotechnology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Luzhu Biotechnology Co's Other Stockholders Equity compare to VRTX and REGN?
Beijing Luzhu Biotechnology Co's Other Stockholders Equity of HK$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Beijing Luzhu Biotechnology Co and its competitors. Beijing Luzhu Biotechnology Co's current Other Stockholders Equity is HK$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Luzhu Biotechnology Co stock overvalued right now?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a current Other Stockholders Equity of HK$0.00 Mil. The current Other Stockholders Equity is HK$0.00 Mil. Beijing Luzhu Biotechnology Co's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Beijing Luzhu Biotechnology Co (HKSE:02480), the current Other Stockholders Equity is HK$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beijing Luzhu Biotechnology Co Business Description

Address No. 3 Guangtong Street, Industrial Development Zone, Zhangjiawan Tongzhou District, Beijing, CHN
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
24GF Score

Get the complete analysis for HKSE:02480

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.00
Price